Apollo Medical Holdings, Inc. AMEH
We take great care to ensure that the data presented and summarized in this overview for Apollo Medical Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AMEH
View all-
Black Rock Inc. New York, NY6.38MShares$234 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$173 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$57.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.23MShares$45.3 Million0.01% of portfolio
-
325 Capital LLC New York, NY1.19MShares$43.8 Million14.84% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$37.3 Million0.0% of portfolio
-
Steel Peak Wealth Management LLC580KShares$21.3 Million0.75% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA562KShares$20.6 Million0.0% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ501KShares$18.4 Million0.08% of portfolio
-
Morgan Stanley New York, NY498KShares$18.3 Million0.0% of portfolio
Latest Institutional Activity in AMEH
Top Purchases
Top Sells
About AMEH
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Insider Transactions at AMEH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2025
|
Thomas S. Lam Director |
SELL
Payment of exercise price or tax liability
|
Direct |
25,866
-5.63%
|
$569,052
$22.0 P/Share
|
|
Dec 08
2025
|
Thomas S. Lam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,502
+6.04%
|
$501,534
$17.78 P/Share
|
|
Nov 10
2025
|
Kenneth T. Sim Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
29,502
+4.41%
|
$501,534
$17.78 P/Share
|
|
Nov 10
2025
|
Matthew Mazdyasni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+36.52%
|
$360,000
$18.2 P/Share
|
|
Nov 07
2025
|
Mitchell W Kitayama Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+30.12%
|
$216,000
$18.2 P/Share
|
|
Nov 03
2025
|
Linda Marsh Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,033
-10.65%
|
$353,056
$32.99 P/Share
|
|
Nov 03
2025
|
Linda Marsh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+16.18%
|
$360,000
$18.2 P/Share
|
|
Oct 02
2025
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,979
-1.12%
|
$53,433
$27.77 P/Share
|
|
Sep 15
2025
|
Mitchell W Kitayama Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,214
-26.14%
|
$396,420
$30.23 P/Share
|
|
Sep 15
2025
|
Mitchell W Kitayama Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+21.59%
|
$144,000
$18.2 P/Share
|
|
Sep 05
2025
|
Dinesh M. Kumar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,694
-0.77%
|
$49,126
$29.7 P/Share
|
|
Sep 05
2025
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,694
-0.95%
|
$49,126
$29.7 P/Share
|
|
Sep 02
2025
|
David Schmidt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,000
-55.92%
|
$540,000
$27.76 P/Share
|
|
Sep 02
2025
|
David Schmidt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+35.87%
|
$360,000
$18.2 P/Share
|
|
Aug 13
2025
|
John Chiang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,284
-28.48%
|
$356,236
$29.63 P/Share
|
|
Aug 13
2025
|
John Chiang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+31.68%
|
$360,000
$18.2 P/Share
|
|
Jul 01
2025
|
Dinesh M. Kumar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,831
-3.03%
|
$170,775
$25.06 P/Share
|
|
Jun 11
2025
|
Linda Marsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+7.16%
|
-
|
|
Jun 11
2025
|
Matthew Mazdyasni Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+30.4%
|
-
|
|
Jun 11
2025
|
David Schmidt Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,449
+29.03%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 252K shares |
|---|---|
| Exercise of conversion of derivative security | 159K shares |
| Other acquisition or disposition | 52.5K shares |
| Payment of exercise price or tax liability | 209K shares |
|---|---|
| Sale (or disposition) back to the issuer | 333K shares |
| Other acquisition or disposition | 2.1M shares |